Search

You searched for "balanc"

3816 results found

LearnENT app – bringing otolaryngology to your mobile

10 July 2017 | ENTA - ENT
www.learnent.ca ENT trainees, medical students, and audiologists take note: an app called LearnENT is about to bring the fundamentals of otolaryngology right to your fingertips. A team of otolaryngologists and medical residents at the University of Ottawa developed LearnENT as...

COVID-19 Video Resources

13 May 2020 | ENTA - General
Click on the boxes below for tutorials and advice  

Neuromod establishes US subsidiary and appoints Eric Timm as US Chief Executive Officer

19 October 2021 | Company Profiles, Recruitment & Personnel
Neuromod Devices Ltd, the Irish medical device company which specialises in neuromodulation technologies, has announced the establishment of Neuromod USA Inc., a subsidiary headquartered in Oak Brook, Illinois.

Signia UK announces partnership with EARWAYS Medical Ltd for distribution

17 December 2021 | Company Profiles, Contracts & Distributors, Research & Development
The EarWay® Pro by EARWAYS Medical is now available on the NHS Supply Chain Framework

Breakthrough tinnitus device Lenire available in three new clinics in Spain

19 April 2024 | Company Profiles, Contracts & Distributors
Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.

Soluvos Medical: exclusive A.R.C. Laser partner in the UK from 1 March 2025

3 March 2025 | Contracts & Distributors
Soluvos Medical is delighted to announce that, as of 1 March 2025, they will be the exclusive A.R.C. Laser partner in the UK. Driven by a commitment to clinical excellence and innovation, Soluvos Medical is proud to deliver state-of-the-art laser...

Nature Communications Medicine publishes positive, real-world data for tinnitus patients treated with unique, FDA approved stimulation device

9 May 2025 | Company Profiles, Research & Development
Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...

Soluvos Medical wishes readers a lovely summer season

24 June 2025 | Company Profiles
Soluvos Medical had a busy conference schedule leading up to the summer break, and the team is now recharging and looking forward to meeting readers again at the next symposia and hands-on courses after the summer break. Find the Soluvos...

Neuromod expands availability of Lenire tinnitus treatment device in Europe with 19 new clinical partnerships

1 October 2025 | Company Profiles
Neuromod Devices, the technology company that specialises in medical devices for tinnitus treatment, has announced 19 new clinical partnerships to expand the availability of the Lenire tinnitus treatment device in Europe. This latest expansion will significantly increase the number of...

RSM ‘Otology Dragon’s Den’ - Interview with Professor Gerard O’Donoghue

1 September 2014 | | ENTA - Otology
Paula Bradley interviews Professor Gerard O’Donoghue, President Elect, Otology Section Council; Royal Society of Medicine on the upcoming ‘Otology Dragons’ Den’ event. Tell me a bit about the proposed event? When is it? Where? This event, the ‘Otology Dragons’ Den’,...

Leadership in academia

1 September 2014 | | ENTA - ENT
I went into medicine with the clichéd view of wanting to help people. I found that by doing surgery I could help a small number of people, albeit usually to a large effect. Then, I recognised that by engaging in...

National selection: is the research section of the portfolio fit for purpose?

3 November 2022 | | ENTA - ENT
Applications for ENT training roles in every country require certain criteria to be met. In the UK, ST3 recruitment applications have scores allocated to research experience. In this opinion piece, the authors share their assessment of the potential issues around...